nodes	percent_of_prediction	percent_of_DWPC	metapath
Ingenol Mebutate—PRKCD—Oncostatin M Signaling Pathway—TIMP3—age related macular degeneration	0.0397	0.0442	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Melatonin metabolism and effects—MAP2—age related macular degeneration	0.0388	0.0432	CbGpPWpGaD
Ingenol Mebutate—PRKCD—connective tissue—age related macular degeneration	0.0381	0.372	CbGeAlD
Ingenol Mebutate—PRKCA—Inactivation, recovery and regulation of the phototransduction cascade—RHO—age related macular degeneration	0.035	0.039	CbGpPWpGaD
Ingenol Mebutate—PRKCA—The phototransduction cascade—RHO—age related macular degeneration	0.0341	0.038	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Diseases associated with visual transduction—RDH8—age related macular degeneration	0.0239	0.0266	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Response to elevated platelet cytosolic Ca2+—SERPING1—age related macular degeneration	0.0228	0.0254	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Oncostatin M Signaling Pathway—TIMP3—age related macular degeneration	0.0228	0.0254	CbGpPWpGaD
Ingenol Mebutate—PRKCA—eye—age related macular degeneration	0.0218	0.213	CbGeAlD
Ingenol Mebutate—PRKCA—retina—age related macular degeneration	0.0216	0.211	CbGeAlD
Ingenol Mebutate—PRKCA—connective tissue—age related macular degeneration	0.021	0.205	CbGeAlD
Ingenol Mebutate—PRKCA—Diseases associated with visual transduction—RPE65—age related macular degeneration	0.0209	0.0233	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Platelet activation, signaling and aggregation—SERPING1—age related macular degeneration	0.0185	0.0206	CbGpPWpGaD
Ingenol Mebutate—PRKCD—VEGFR2 mediated cell proliferation—KDR—age related macular degeneration	0.0171	0.0191	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Diseases associated with visual transduction—ABCA4—age related macular degeneration	0.0168	0.0188	CbGpPWpGaD
Ingenol Mebutate—PRKCD—IL-6 signaling pathway—CRP—age related macular degeneration	0.0148	0.0165	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Diseases associated with visual transduction—RHO—age related macular degeneration	0.0146	0.0163	CbGpPWpGaD
Ingenol Mebutate—PRKCD—IL6-mediated signaling events—CRP—age related macular degeneration	0.0138	0.0153	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cardiac Hypertrophic Response—TGFBR1—age related macular degeneration	0.0127	0.0142	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Melatonin metabolism and effects—APOE—age related macular degeneration	0.0114	0.0127	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Platelet activation, signaling and aggregation—SERPING1—age related macular degeneration	0.0106	0.0118	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—F13B—age related macular degeneration	0.0101	0.0113	CbGpPWpGaD
Ingenol Mebutate—PRKCA—VEGFR2 mediated cell proliferation—KDR—age related macular degeneration	0.00982	0.0109	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling events mediated by VEGFR1 and VEGFR2—KDR—age related macular degeneration	0.00982	0.0109	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—SERPING1—age related macular degeneration	0.00954	0.0106	CbGpPWpGaD
Ingenol Mebutate—PRKCD—VEGFR2 mediated cell proliferation—VEGFA—age related macular degeneration	0.00942	0.0105	CbGpPWpGaD
Ingenol Mebutate—PRKCD—BDNF signaling pathway—SQSTM1—age related macular degeneration	0.0093	0.0104	CbGpPWpGaD
Ingenol Mebutate—PRKCD—MAPK Signaling Pathway—TGFBR1—age related macular degeneration	0.00907	0.0101	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Extracellular matrix organization—COL8A1—age related macular degeneration	0.00874	0.00974	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Oncostatin M Signaling Pathway—CCL2—age related macular degeneration	0.00874	0.00974	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—C9—age related macular degeneration	0.00859	0.00957	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Extracellular matrix organization—FBLN5—age related macular degeneration	0.00834	0.00929	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Extracellular matrix organization—EFEMP1—age related macular degeneration	0.00834	0.00929	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—RAD51B—age related macular degeneration	0.00827	0.00921	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Corticotropin-releasing hormone—TLR4—age related macular degeneration	0.00771	0.00859	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—SLC16A8—age related macular degeneration	0.00769	0.00857	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—CFI—age related macular degeneration	0.00745	0.0083	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Extracellular matrix organization—ADAMTS9—age related macular degeneration	0.00743	0.00828	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Extracellular matrix organization—COL10A1—age related macular degeneration	0.00743	0.00828	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—CFHR3—age related macular degeneration	0.00692	0.00771	CbGpPWpGaD
Ingenol Mebutate—PRKCD—VEGFA-VEGFR2 Pathway—KDR—age related macular degeneration	0.00684	0.00762	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Pathogenic Escherichia coli infection—TLR4—age related macular degeneration	0.00669	0.00745	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by VEGF—KDR—age related macular degeneration	0.00645	0.00719	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—C2—age related macular degeneration	0.00617	0.00687	CbGpPWpGaD
Ingenol Mebutate—PRKCA—VEGFR1 specific signals—VEGFA—age related macular degeneration	0.00615	0.00685	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—F13B—age related macular degeneration	0.00583	0.00649	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling events mediated by VEGFR1 and VEGFR2—KDR—age related macular degeneration	0.00564	0.00629	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Oncostatin M Signaling Pathway—VEGFA—age related macular degeneration	0.00561	0.00625	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—SERPING1—age related macular degeneration	0.00548	0.0061	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Cytokine Signaling in Immune system—SQSTM1—age related macular degeneration	0.00546	0.00609	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Response to elevated platelet cytosolic Ca2+—CD36—age related macular degeneration	0.00546	0.00608	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling events mediated by VEGFR1 and VEGFR2—VEGFA—age related macular degeneration	0.00541	0.00603	CbGpPWpGaD
Ingenol Mebutate—PRKCA—VEGFR2 mediated cell proliferation—VEGFA—age related macular degeneration	0.00541	0.00603	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by NGF—SQSTM1—age related macular degeneration	0.00537	0.00599	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—NMNAT1—age related macular degeneration	0.00528	0.00589	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—RDH8—age related macular degeneration	0.00528	0.00589	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—CST3—age related macular degeneration	0.00524	0.00583	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—CFH—age related macular degeneration	0.00516	0.00575	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Oncostatin M Signaling Pathway—CCL2—age related macular degeneration	0.00502	0.00559	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—CFB—age related macular degeneration	0.005	0.00558	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—C9—age related macular degeneration	0.005	0.00557	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—C9—age related macular degeneration	0.00493	0.0055	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—RAD51B—age related macular degeneration	0.00475	0.00529	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—TGFBR1—age related macular degeneration	0.0047	0.00524	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—RPE65—age related macular degeneration	0.00462	0.00515	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Corticotropin-releasing hormone—TLR4—age related macular degeneration	0.00443	0.00494	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Platelet activation, signaling and aggregation—CD36—age related macular degeneration	0.00443	0.00493	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—SLC16A8—age related macular degeneration	0.00442	0.00492	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Diseases associated with visual transduction—APOE—age related macular degeneration	0.00441	0.00491	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—CFI—age related macular degeneration	0.00434	0.00483	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—ERCC6—age related macular degeneration	0.00431	0.0048	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—CFI—age related macular degeneration	0.00428	0.00476	CbGpPWpGaD
Ingenol Mebutate—PRKCD—GPCR downstream signaling—RHO—age related macular degeneration	0.00423	0.00471	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—CFHR3—age related macular degeneration	0.00403	0.00449	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—CFHR3—age related macular degeneration	0.00398	0.00443	CbGpPWpGaD
Ingenol Mebutate—PRKCA—VEGFA-VEGFR2 Pathway—KDR—age related macular degeneration	0.00393	0.00437	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—RHO—age related macular degeneration	0.00384	0.00428	CbGpPWpGaD
Ingenol Mebutate—PRKCD—VEGFA-VEGFR2 Pathway—VEGFA—age related macular degeneration	0.00377	0.0042	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—ABCA4—age related macular degeneration	0.00372	0.00415	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by VEGF—KDR—age related macular degeneration	0.00371	0.00413	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—RDH8—age related macular degeneration	0.0037	0.00412	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Spinal Cord Injury—TLR4—age related macular degeneration	0.00363	0.00405	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—C2—age related macular degeneration	0.00359	0.004	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by VEGF—VEGFA—age related macular degeneration	0.00355	0.00396	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—C2—age related macular degeneration	0.00354	0.00395	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—RHO—age related macular degeneration	0.00324	0.00361	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—RPE65—age related macular degeneration	0.00323	0.0036	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Oncostatin M Signaling Pathway—VEGFA—age related macular degeneration	0.00322	0.00359	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Spinal Cord Injury—CCL2—age related macular degeneration	0.00311	0.00347	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling events mediated by VEGFR1 and VEGFR2—VEGFA—age related macular degeneration	0.00311	0.00346	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—SQSTM1—age related macular degeneration	0.00309	0.00344	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—RDH8—age related macular degeneration	0.00303	0.00338	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—NMNAT1—age related macular degeneration	0.00303	0.00338	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—CFH—age related macular degeneration	0.00301	0.00335	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—CFH—age related macular degeneration	0.00296	0.0033	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—CFB—age related macular degeneration	0.00291	0.00325	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—CFB—age related macular degeneration	0.00287	0.0032	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—C9—age related macular degeneration	0.00287	0.0032	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—RPE65—age related macular degeneration	0.00265	0.00296	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—ABCA4—age related macular degeneration	0.00261	0.0029	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Response to elevated platelet cytosolic Ca2+—VEGFA—age related macular degeneration	0.0026	0.0029	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Platelet activation, signaling and aggregation—CD36—age related macular degeneration	0.00254	0.00283	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—NMNAT1—age related macular degeneration	0.00254	0.00283	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CFI—age related macular degeneration	0.00249	0.00278	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—ERCC6—age related macular degeneration	0.00248	0.00276	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—RHO—age related macular degeneration	0.00243	0.0027	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CFHR3—age related macular degeneration	0.00232	0.00258	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—CD36—age related macular degeneration	0.00228	0.00254	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—RHO—age related macular degeneration	0.00227	0.00253	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—ELOVL4—age related macular degeneration	0.00222	0.00247	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—RHO—age related macular degeneration	0.0022	0.00246	CbGpPWpGaD
Ingenol Mebutate—PRKCA—VEGFA-VEGFR2 Pathway—VEGFA—age related macular degeneration	0.00216	0.00241	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—ABCA4—age related macular degeneration	0.00214	0.00238	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—RDH8—age related macular degeneration	0.00212	0.00237	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Platelet activation, signaling and aggregation—VEGFA—age related macular degeneration	0.00211	0.00235	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—C2—age related macular degeneration	0.00206	0.0023	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—CD36—age related macular degeneration	0.00205	0.00229	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by VEGF—VEGFA—age related macular degeneration	0.00204	0.00227	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—CST3—age related macular degeneration	0.00202	0.00226	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—C3—age related macular degeneration	0.00195	0.00217	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Extracellular matrix organization—KDR—age related macular degeneration	0.00191	0.00212	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—RHO—age related macular degeneration	0.00186	0.00207	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—RPE65—age related macular degeneration	0.00186	0.00207	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—CRP—age related macular degeneration	0.00185	0.00206	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—TGFBR1—age related macular degeneration	0.00182	0.00203	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—SLC16A8—age related macular degeneration	0.00179	0.00199	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—SQSTM1—age related macular degeneration	0.00178	0.00199	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—TLR4—age related macular degeneration	0.00178	0.00198	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CFH—age related macular degeneration	0.00173	0.00192	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CFB—age related macular degeneration	0.00167	0.00187	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—ABCA4—age related macular degeneration	0.0015	0.00167	CbGpPWpGaD
Ingenol Mebutate—PRKCD—GPCR downstream signaling—C3—age related macular degeneration	0.00137	0.00152	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—VEGFA—age related macular degeneration	0.00136	0.00152	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—CD36—age related macular degeneration	0.00131	0.00146	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—RHO—age related macular degeneration	0.0013	0.00145	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—TGFBR1—age related macular degeneration	0.00127	0.00142	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—C3—age related macular degeneration	0.00124	0.00138	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Platelet activation, signaling and aggregation—VEGFA—age related macular degeneration	0.00121	0.00135	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—CD36—age related macular degeneration	0.0012	0.00133	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—CD36—age related macular degeneration	0.00118	0.00131	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—CST3—age related macular degeneration	0.00116	0.0013	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—SQSTM1—age related macular degeneration	0.00115	0.00129	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—C3—age related macular degeneration	0.00113	0.00126	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—C3—age related macular degeneration	0.00112	0.00125	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—VEGFA—age related macular degeneration	0.00109	0.00121	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—CRP—age related macular degeneration	0.00108	0.0012	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—CRP—age related macular degeneration	0.00106	0.00119	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—TGFBR1—age related macular degeneration	0.00104	0.00116	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—TLR4—age related macular degeneration	0.00103	0.00115	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—SQSTM1—age related macular degeneration	0.00103	0.00114	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—TLR4—age related macular degeneration	0.00102	0.00114	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—APOE—age related macular degeneration	0.000975	0.00109	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—CCL2—age related macular degeneration	0.000971	0.00108	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—LIPC—age related macular degeneration	0.000917	0.00102	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—CETP—age related macular degeneration	0.000884	0.000985	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—C3—age related macular degeneration	0.000785	0.000875	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—C3—age related macular degeneration	0.000733	0.000817	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—TGFBR1—age related macular degeneration	0.000731	0.000815	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—C3—age related macular degeneration	0.000713	0.000794	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CD36—age related macular degeneration	0.000687	0.000766	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—APOE—age related macular degeneration	0.000683	0.00076	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—KDR—age related macular degeneration	0.000669	0.000745	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—SQSTM1—age related macular degeneration	0.000663	0.000739	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—C3—age related macular degeneration	0.000651	0.000726	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—VEGFA—age related macular degeneration	0.000624	0.000695	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CRP—age related macular degeneration	0.00062	0.00069	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—TLR4—age related macular degeneration	0.000594	0.000662	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—CCL2—age related macular degeneration	0.000574	0.000639	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—APOE—age related macular degeneration	0.00056	0.000624	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—CCL2—age related macular degeneration	0.000558	0.000621	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—CD36—age related macular degeneration	0.000531	0.000592	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—APOE—age related macular degeneration	0.000469	0.000522	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—C3—age related macular degeneration	0.000421	0.000469	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—APOE—age related macular degeneration	0.000392	0.000437	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—KDR—age related macular degeneration	0.000384	0.000428	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—VEGFA—age related macular degeneration	0.000368	0.00041	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CCL2—age related macular degeneration	0.000329	0.000367	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—VEGFA—age related macular degeneration	0.000212	0.000236	CbGpPWpGaD
